Research Study to Compare the Addition of Topaz Micro Debridement to the Standard of Care Surgery

May 23, 2017 updated by: Smith & Nephew, Inc.

A Randomised, Controlled, Double-blind Clinical Investigation on the Efficacy and Safety of Radiofrequency Micro Debridement, Topaz, in Recalcitrant Greater Trochanteric Pain Syndrome (GTPS) vs. Standard of Care

Compare the surgical use of Topaz with the Standard Of Care in the treatment of Greater Trochanteric Pain Syndrome (a type of hip pain). The hypothesis is that there is a difference between the two treatment groups.

Study Overview

Study Type

Interventional

Enrollment (Actual)

66

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Victoria
      • Richmond, Victoria, Australia, 3121
        • Epworth Private Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

38 years to 68 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Female or male aged between 40-70 years old, females and males are eligible
  2. A history of > 6 months of conservative care treatment for lateral hip pain, including but not limited to local anaesthetic and steroid injections into the trochanteric bursa
  3. Pre-operative MRI and ultrasound with evidence of GTPS within the previous 24 weeks
  4. Willing to comply with the protocol and follow-up visits
  5. Signed the Independent Ethics Committee (IEC) approved Informed Consent Form

Exclusion Criteria:

  1. Previous surgery to the hip such as hip replacement, fracture neck of femur fixation, or repair of gluteal tendons
  2. Subjects with sero-positive or sero-negative arthropathy
  3. Long term steroid use > 6 weeks
  4. Allergy to drugs to be used in the procedure
  5. Medical co-morbidities that preclude surgical intervention
  6. Inability to understand or respond to the study questionnaires
  7. Females who are pregnant, or pregnancy is suspected or planned within the clinical investigation timeframe
  8. Subjects who are simultaneously participating in another device or pharmaceutical investigation

Intra-operative Exclusion:

  1. Abductor tears
  2. Severe tendinopathy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group 2
Standard of Care: An iliotibial band release and trochanteric bursectomy will be performed.
Other Names:
  • Standard of Care
Experimental: Group 1
Radiofrequency micro debridement with Topaz will be used to treat the gluteal tendons following standard of care procedure
Other Names:
  • Topaz AC-4045-01

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Modified Harris Hip Score
Time Frame: 6 months
This is a patient questionnaire used to evaluate hip function following surgery.
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adverse events
Time Frame: 1 year
1 year
The Western Ontario and McMaster Universities Arthritis Index
Time Frame: 1 year
This is a patient questionnaire used to evaluate rheumatic symptoms, stiffness, pain and how it affects the ability to function.
1 year
Visual Analogue Scale
Time Frame: 1 year
This is a patient questionnaire designed to evaluate pain.
1 year
SF-12 Health Survey
Time Frame: 1 year
This is a patient questionnaire measuring health-related quality of life.
1 year
Duration of surgery between two treatment groups
Time Frame: 1 day
The total length (time) of surgery will be compared between the two groups.
1 day
Ultrasound findings
Time Frame: 1 year
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: John O'Donnell, M.B., B.S.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2012

Primary Completion (Actual)

October 1, 2016

Study Completion (Actual)

October 1, 2016

Study Registration Dates

First Submitted

March 22, 2012

First Submitted That Met QC Criteria

March 22, 2012

First Posted (Estimate)

March 23, 2012

Study Record Updates

Last Update Posted (Actual)

May 25, 2017

Last Update Submitted That Met QC Criteria

May 23, 2017

Last Verified

May 1, 2017

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Pain Chronic

Clinical Trials on Topaz

3
Subscribe